Contact Information: Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 Diane Meegan Investor Relations 212-330-8512
Daxor Announces Oregon Health and Science University of Portland, OR Acquires BVA-100 Blood Volume Analyzer
| Source: Daxor Corp.
NEW YORK, NY--(Marketwire - September 24, 2007) - Daxor Corporation (AMEX : DXR ), a medical
instrumentation and biotechnology company, today announced the receipt of a
signed trial agreement from the Oregon Health and Science University,
Portland, Oregon.
Oregon's Health and Science University (OHSU) is the state's only health
and research university. As part of its multifaceted public mission, OHSU
strives for excellence in scholarship, research, clinical practice and
community service. OHSU strives to provide high-quality health care
emphasizing the development and dissemination of new knowledge and
cutting-edge technology.
OHSU employs 11,500 people and is Portland's largest business with an
annual budget of $1.18 billion. Approximately 52% of its annual budget
contributes to patient care for 447 staffed beds at OHSU Hospital and
Doernbecher Children's Hospital.
In keeping with OHSU's mission to develop and disseminate cutting-edge
technology, Daxor's BVA-100 Blood Volume Analyzer will be utilized to
measure intravascular blood volume on critically injured patients to
diagnose the blood volume status post-injury and post-operatively. Current
practices associated with treatment of these types of patients currently
relies on surrogate markers such as the hematocrit, heart rate, blood
pressure and highly invasive procedures which measure pressures and various
hemodynamic variables but do not measure a patient's intravascular blood
volume. OHSU's use of the BVA-100 will quantify the improvements to
patient care and patient outcomes by utilizing a direct measured blood
volume provided by the BVA-100 versus the use of surrogate markers and
surrogate measurements.
Daxor's Blood Volume Analyzer BVA-100 is the only FDA-approved instrument
for the direct measurement of a patient's intravascular blood volume.
Daxor Corporation manufactures and markets the BVA-100, a semi-automated
Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex,
Daxor's single use diagnostic kit. For more information regarding Daxor
Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website
www.Daxor.com.